Quest Diagnostics Incorporated Stock price
Equities
DGX
US74834L1008
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
128.1 USD | -0.11% | -1.00% | -7.06% |
Financials (USD)
Sales 2024 * | 9.4B | Sales 2025 * | 9.72B | Capitalization | 14.19B |
---|---|---|---|---|---|
Net income 2024 * | 886M | Net income 2025 * | 955M | EV / Sales 2024 * | 1.91 x |
Net Debt 2024 * | 3.77B | Net Debt 2025 * | 3.18B | EV / Sales 2025 * | 1.79 x |
P/E ratio 2024 * |
16.5
x | P/E ratio 2025 * |
15.1
x | Employees | 44,000 |
Yield 2024 * |
2.26% | Yield 2025 * |
2.33% | Free-Float | 68.04% |
Latest transcript on Quest Diagnostics Incorporated
1 day | -0.11% | ||
1 week | -1.00% | ||
Current month | +2.60% | ||
1 month | +3.34% | ||
3 months | -5.65% | ||
6 months | +1.87% | ||
Current year | -7.06% |
Managers | Title | Age | Since |
---|---|---|---|
James Davis
CEO | Chief Executive Officer | 61 | 13-03-31 |
Sam Samad
DFI | Director of Finance/CFO | 54 | 22-07-10 |
Kristin Wallace
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Denise Morrison
BRD | Director/Board Member | 70 | 19-02-17 |
Timothy Ring
BRD | Director/Board Member | 67 | 11-12-06 |
Gail Wilensky
BRD | Director/Board Member | 80 | 96-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.84% | 227 M€ | +9.20% | - | |
2.17% | 2 M€ | +8.58% | ||
2.05% | 8 M€ | +5.61% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 128.1 | -0.11% | 838,241 |
24-03-15 | 128.3 | +0.91% | 1,954,928 |
24-03-14 | 127.1 | -1.77% | 1,018,880 |
24-03-13 | 129.4 | -0.25% | 849,373 |
24-03-12 | 129.7 | +0.24% | 909,214 |
Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.06% | 14.19B | |
-1.76% | 97.62B | |
+20.87% | 86.54B | |
+11.69% | 29.6B | |
-7.81% | 17.62B | |
+30.79% | 12.02B | |
-31.05% | 11.86B | |
-5.05% | 11.7B | |
+16.31% | 11.92B | |
-9.28% | 11.71B |